Sign in

CIK 0001783036

  • Non-accelerated filer
  • Emerging growth company

NewcelX Ltd.

Sign in to watch
Ticker
NCEL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Switzerland
Entity type
Other
Phone
+41 416188000
Business address
THE CIRCLE 6, 8058, ZURICH, Switzerland
Former names
NLS Pharmaceutics Ltd.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-04-27 Samuel Olivier Director Purchase +81,818 $2.75 $225K 81,818
2026-04-27 Samuel Olivier Director Purchase · Warrant (right to buy) +114,545 114,545
2026-04-27 Revel Michel CSO and Director Purchase +54,545 $2.75 $150K 957,530
2026-04-27 Revel Michel CSO and Director Purchase · Warrant (right to buy) +76,363 76,363

Page 1 of 1 · 4 trades